Citation Tools
Abstracts accepted for publication
Cytokines and inflammatory mediators
AB0057 Soluble pd-1 and spd-l2 are unaffected by adalimumab treatment in early ra and associated with presence of anti-ccp and igm-rf
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- AB0057 Soluble pd-1 and spd-l2 are unaffected by adalimumab treatment in early ra and associated with presence of anti-ccp and igm-rf